By Tara Hayward

We launched the award-winning END7 campaign in 2012 to build a grassroots movement to end the seven most common neglected tropical diseases (NTDs). With your support, we mobilized funding to support programs that treated more than 50 million people, helped increase US and UK funding for NTDs and spread awareness of the global NTD burden. Now, five years later, we are concluding the END7 campaign. We are grateful for the support of all of our followers, student groups and generous donors who made the campaign such a success.

Stay involved in the fight against neglected tropical diseases (NTDs) — join and support these initiatives led by our partners around the globe:

Uniting to Combat NTDs is a partnership of private and public sector organizations working together to defeat 10 NTDs and improve the lives of a billion people. Stay updated with news about NTDs and the amazing progress partners are making across the globe by subscribing to Uniting’s e-newsletter and following Uniting on Twitter!

Looking for a way to continue raising funds for and awareness of NTDs? Consider joining the END Fund for your next adventure! In the past, teams have taken on climbing Mt. Kilimanjaro and pushing themselves to finish the Victoria Falls marathon and half marathon. Contact Abbey Turtinen for more information.

The Carter Center has built hope for millions of the world’s poorest people by distributing more than 500 million doses of donated medication to combat five NTDs in Africa and Latin America. You can help them build hope for millions more by making a donation.

The Global Schistosomiasis Alliance is a coalition of NGOs, development agencies, research institutions and the private sector targeting the debilitating NTD schistosomiasis working to advocate, coordinate and facilitate the necessary networks and activities to reach the WHO’s target for schistosomiasis control and elimination. Learn more on their website, sign up for their newsletter and follow them on Twitter and Facebook.

Sightsavers is an international organization that changes lives for the long term. They work to eliminate avoidable blindness and support people with visual impairments to live independently. This includes work with partners to support programs in 29 countries targeting five NTDs. In 2016 Sightsavers supported a record number of treatments: more than 154 million. Follow @Sightsavers and @SightsaversUSA on Twitter or like Sightsavers on Facebook to share posts and show your support.

Every two minutes someone is diagnosed with leprosy and more than 4 million people suffer from lifelong disabilities caused by this devastating neglected tropical disease. Although leprosy can be cured, there is no vaccine to prevent it. But finally, after 15 years of research and development, the world’s first leprosy-specific vaccine is ready for Phase I clinical trials. Donate now to American Leprosy Missions stop the suffering and help end this ancient disease once and for all.

PATH is developing treatments for NTDs to make more lifesaving medicines available and add new tools to the fight against drug resistance. Learn more about how PATH is working with countries and partners worldwide to find the best ways to deploy the NTD-fighting tools we already have, advance new tools and tackle the root causes of infection so that children and communities can thrive.

The London Centre for NTD Research is an innovative research collaboration that brings together over 200 NTD experts from leading research institutions based in London undertaking cutting-edge research to build the evidence base around the design, implementation and evaluation of NTD control and elimination programs. Visit their NTD research directory, sign up for their research newsletter and follow @NTDresearch to learn more.

CaringCrowd® is an award-winning crowdfunding platform proudly sponsored by Johnson & Johnson that is dedicated to supporting community health projects (including ones addressing NTDs) anywhere in the world.  Every project on the platform is sponsored by a non-profit and has been reviewed by a team of experts. There are many ways you can get involved, from pledging, to posting a campaign, or advocating for a cause you support. Visit www.CaringCrowd.org or contact help@caringcrowd.org to get started.

For more on NTD philanthropy, Give Well publishes a Deworming Report and their selected top charities include several organizations active in NTD control and elimination programs.

With the help of our supporters, the END7 campaign achieved amazing things – mobilizing funding to treat more than 50 million people, raising the volume of global advocacy and building a movement to end the suffering caused by NTDs. The Sabin Vaccine Institute remains committed to improving health around the world through our renewed focus on immunization. We are deeply grateful for everyone’s commitment and contributions to the END7 campaign!

by Kathryn McGrath

It’s been five years since the Sabin Vaccine Institute launched the END7 campaign to end neglected tropical diseases (NTDs). With your support, we mobilized funding to support programs that treated more than 50 million people, helped increase US and UK funding for NTDs and spread awareness of the global NTD burden.

As of June 1, 2017 we are no longer accepting donations for NTD treatment programs but we are working to ensure END7 advocacy efforts continue uninterrupted. We have concluded END7 fundraising activities and are working with a partner organization to continue advocacy for NTD treatment. END7 student advocacy efforts will continue this fall under the direction of another NTD organization, we will share more details about this exciting transition soon.

The Sabin Vaccine Institute, home of the END7 campaign, is dedicated to making vaccines more accessible, enabling innovation and expanding immunization across the globe. We intend to focus our energy going forward on expanding immunization. Learn more about Sabin’s mission and Sabin’s work.

Over the last decade Sabin was proud to be a part of the global fight against NTDs, mobilizing more than $165 million in resources, generating political will among endemic and donor countries and engaging the public to advocate for greater investment in NTD treatment. Sabin helped build a movement that has succeeded in bringing several NTDs to the brink of elimination.

More people than ever before are receiving treatment and many countries have eliminated NTDs such as elephantiasis and trachoma. As we conclude END7 fundraising, we are proud to have played a role in the global fight against NTDs.

We plan to award the balance of END7 donations received to date to control and eliminate elephantiasis and intestinal worms in Guyana. These funds will make a critical impact on Guyana’s effort to wrap up elephantiasis elimination activities by 2023 – a big step towards the goal of wiping out this disfiguring disease across the Americas.

Sabin always works closely with countries to plan and improve health care projects, whether it is NTD treatment or immunization programs. Today many of the countries we have partnered with to fight NTDs are stepping up to fund and run their own NTD programs, ensuring that the fight against these diseases is sustainable and the progress we have made will last.

Since the launch of our campaign, generous donors have helped deliver deworming pills to more than one million schoolchildren in Honduras, train more than 90,000 community health workers to carry out a national mass drug administration campaign in Myanmar and taught more than 1,500 people with the NTD lymphatic filariasis in India how to care for their painfully swollen limbs.

This work is a proud chapter in Sabin’s legacy as we continue our mission with a renewed focus on vaccine-preventable diseases.  We remain grateful for your support and participation in END7 on behalf of people living in poverty and suffering from NTDs.

Stay tuned for an update about how you can stay engaged in the fight against NTDs. If you wish to continue donating to support NTD treatment, check out GiveWell’s recommendations of top charities.

The END7 campaign, through the support of Uniting to Combat NTDs, awarded scholarships to three outstanding student leaders to attend the third annual NTD Student Advocacy Day in Washington, D.C. Read scholarship winner Paige Bagby’s reflection on her experience:

By Paige Bagby, DePauw University

Almost two years ago, I walked into an hour-long lecture on neglected tropical diseases (NTDs) at DePauw University. Emily Conron, the Senior Associate of Resource Development & Policy at the Sabin Vaccine Institute and coordinator of student outreach for the END7 campaign, inspired me with an introductory lecture on the seven most common NTDs and the global effort to control and eliminate them. I stayed after the talk determined to get involved in this effort and learned about the work of END7, a grassroots campaign of the Sabin Vaccine Institute dedicated to raising the awareness, funds and political will necessary to control and eliminate the seven most common NTDs. Since August of 2015, I have been working to launch an END7 chapter here at DePauw. This May, I was given a life-changing opportunity to travel to Capitol Hill to put everything I’ve learned into action on the third annual NTD Student Advocacy Day.

After my classes on May 1^st, I drove to the Indianapolis Airport and boarded a plane to Washington, D.C. Right before boarding, I received a schedule detailing that I would be meeting with the congressional staff of Senators Todd Young, Mitch McConnell, Lindsey Graham, Dianne Feinstein and Roger Wicker. Overwhelmed with excitement, I memorized the biographies and policy interests of each senator.

The next morning, I arrived at the Capitol Visitors Center. While waiting in line to go through security, Bailey Miller, a Global Health major at Georgetown University and my host for the trip, and I quizzed each other on NTD facts, conversation starters for meetings with staffers, and much more. But most importantly, we tried to find the words to articulate that what we were advocating for is so important to the greater good of the world.

Standing in line with approximately 24 other students, all from different backgrounds, experiences and schools, I realized our common interests. I was inspired by the passion I saw in these students from all over the country – from Texas, Indiana, Massachusetts, Kentucky, California and more – advocating for treatment for diseases that may never personally affect them. We passed through security to go to our first destination, a briefing by representatives of global health organizations including the Sabin Vaccine Institute, Uniting to Combat Neglected Tropical Diseases, Helen Keller International, and RTI International. The speakers shared the stories of their work, research and personal experiences with NTDs. That is when I realized the truth of Mahatma Gandhi’s famous saying, “It is health that is real wealth and not pieces of gold and silver.” As I prepared to walk into crucial meetings to advocate to protect funding for the United States Agency for International Development (USAID) NTD Program for fiscal year 2018, I kept that thought in the back of my mind: to be without health is to be without a full life.

Walking into each senator’s offices, we all had the chance to make a difference and to make a change. The USAID NTD program works in solidarity with over 30 countries to control and eliminate the seven most common neglected tropical diseases, which infect 1 in 6 people worldwide, debilitating, disabling, and killing some of the world’s poorest people. Taking everything I have learned about global health and NTDs, I walked into my first meeting of the day with my very own senator, Todd Young of Indiana. This meeting was a life-changing experience. I had the opportunity to explain that as his constituent I am incredibly proud to say my tax dollars support USAID’s global health efforts, especially the NTD Program, because I know that eliminating these diseases will lead to a greater world. A decrease in NTD infections leads to an increase in education, economic prosperity, nutrition and maternal and child health. I carried this same passion to my next four meetings.

To wrap up a remarkable day, I had the incredible honor of attending a reception re-capping the NTD Summit which took place in Geneva, Switzerland to mark the 5-year anniversary of the World Health Organization’s Roadmap on NTDs and the London Declaration. Presented at the Summit and pictured here is the Guinness World Record awarded to Uniting to Combat Neglected Tropical Diseases for setting the record for “most medication donated in 24 hours” – more than 207 million doses of drugs to treat NTDs.

I was incredibly sad to say goodbye to all the wonderful students and global health experts I met throughout Student Advocacy Day. But, I was also incredibly humbled and honored by the experience the Sabin Vaccine Institute and other Advocacy Day partners provided me. I know the conversations I had that day and the things I learned will help prepare me for my future career in global health. The experience also reminded me that each person can make a difference whether that be by fundraising, volunteering or advocating.

Paige Bagby is a sophomore at DePauw University studying Global Health and Spanish.

The END7 campaign, through the support of Uniting to Combat NTDs, awarded scholarships to three outstanding student leaders to attend the third annual NTD Student Advocacy Day in Washington, D.C. Read scholarship winner Bethany Summerford’s reflection on her experience:

By Bethany Summerford, University of Mississippi Medical Center

I first learned about END7 last fall at the beginning of my first year of medical school when I attended a lecture that promised free lunch on my campus. When the hour was over, I walked away with much more than a stomach full of pizza. Learning about END7 and the struggles so many of the world’s poorest people deal with every day due to neglected tropical diseases (NTDs) compelled me to become more involved. I joined the Global Health Interest Group at the University of Mississippi Medical Center in hopes to do more to help further the END7 campaign’s goals. When I heard about NTD Student Advocacy Day and was invited to attend, I jumped at the chance to advocate for global health funding through the United States Agency for International Development (USAID).

My day in Washington, D.C., began with coffee at Mississippi Mornings, a constituent coffee held each Tuesday by Senator Roger Wicker in his D.C. office. Not only is Sen. Wicker the senator of my home state, he is also Chairman of the Malaria and NTD Caucus. Having the opportunity to have a quick chat and snap a picture with someone who is so passionate about this cause was a great way to kick off the day.

I spent the rest of the morning with my fellow Advocacy Day participants in a briefing where representatives of several organizations involved in NTD advocacy, programming and research gave presentations and updates on their roles in eliminating these diseases. The one presentation that spoke to me the most was given by Zeina Sifri from Helen Keller International (HKI). Ms. Sifri spoke about eyelid surgery used to treat trichiasis, which is the stage of trachoma infection that causes blindness due to eyelashes scratching the cornea.

Sifri introduced us to the HEAD START program, where surgeons are able to practice the trichiasis surgery on a mannequin designed to simulate patients they will see in areas affected by trachoma. As a future health care provider, I was amazed at the innovation and creativity needed to prepare physicians to treat NTDs in the field. Watching videos of patients who have received the surgery and hearing about the positive turn their lives had taken made me see the real impact of these surgeries, funded through the USAID NTD Program.

Following the morning briefing, we were broken up into small groups and began to plan our strategies for the afternoon meetings in congressional offices. Each meeting started with our group leader, Michelle Brooks from Uniting to Combat Neglected Tropical Diseases Support Centre, giving a brief overview of END7, NTDs, and the need to protect funding for the USAID NTD program, which is at risk of being cut.

The two other members of my group and myself then each spoke about the progress that has been made against NTDs and called for continued US support of the cause. One of the coolest marks of progress, in my opinion, is the Guinness World Record recently set by members of the Uniting to Combat NTDs coalition. On January 30th, 2017, these partners donated more than 200 million NTD medicines around the world – enough to set a world record for “most medication donated in 24 hours.” That is so awesome!

My group was able to meet with the offices of senators from Indiana, Kentucky, South Carolina, California and Mississippi. Even though offices from many different states (and different political parties) were represented, they all agreed on how important it is to maintain the current level of funding for global health and development. It was refreshing and encouraging to hear their support for continuing the fight to eliminate NTDs.

Advocacy Day ended with a reception in the Capitol building, where we were all able to see and take pictures with the Guinness World Record. We also had the opportunity to listen to remarks by Loyce Pace, President of Global Health Council, who left us with inspirational words and a charge to continue to advocate for global health. After attending Student Advocacy Day, my passion for fighting NTDs has grown even more. I hope to become more involved with the effort to eliminate NTDs and definitely plan to attend Advocacy Day next year.

Bethany Summerford is a first year medical student at the University of Mississippi Medical Center.